{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:51:48Z","timestamp":1789383108218,"version":"build-2803163510"},"reference-count":20,"publisher":"American Psychiatric Association Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1998,5,1]]},"DOI":"10.1176\/ajp.155.5.660","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T19:55:15Z","timestamp":1418846115000},"page":"660-665","source":"Crossref","is-referenced-by-count":159,"title":["Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease"],"prefix":"10.1176","volume":"155","author":[{"given":"Steven P.","family":"Roose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Woodring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa-Grace V.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J. Thomas","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1555151","doi-asserted-by":"crossref","unstructured":"Williams RB Jr, Sherter C: Cardiac complications of tricyclic antidepressant therapy. Ann Intern Med 1971; 74:395\u2013398","DOI":"10.7326\/0003-4819-74-3-395"},{"key":"R1555153","doi-asserted-by":"crossref","unstructured":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406\u2013412","DOI":"10.1056\/NEJM198908103210629"},{"key":"R1555154","doi-asserted-by":"crossref","unstructured":"Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327:227\u2013233","DOI":"10.1056\/NEJM199207233270403"},{"key":"R1555155","doi-asserted-by":"crossref","unstructured":"Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 1990; 82:1106\u20131116","DOI":"10.1161\/01.CIR.82.4.1106"},{"key":"R1555156","doi-asserted-by":"crossref","unstructured":"Morganroth J, Goin JE: Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias: a meta-analysis. Circulation 1991; 84:1977\u20131983","DOI":"10.1161\/01.CIR.84.5.1977"},{"key":"R1555157","doi-asserted-by":"crossref","unstructured":"Bigger JT Jr: Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment. Am J Cardiol 1990; 65:3D\u201310D","DOI":"10.1016\/0002-9149(90)91410-8"},{"key":"R1555158","doi-asserted-by":"crossref","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, CAST Investigators: Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781\u2013788","DOI":"10.1056\/NEJM199103213241201"},{"key":"R1555159","doi-asserted-by":"crossref","unstructured":"Greenberg HM, Dwyer EM Jr, Hochman JS, Steinberg JS, Echt DS, Peters RW: Interaction of ischaemia and encainide\/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995; 74:631\u2013635","DOI":"10.1136\/hrt.74.6.631"},{"key":"R15551510","doi-asserted-by":"crossref","unstructured":"Glassman AH, Roose SP, Bigger JT Jr: The safety of tricyclic anti~depressants in cardiac patients: risk\/benefit reconsidered. JAMA 1993; 269:2673\u20132675","DOI":"10.1001\/jama.269.20.2673"},{"key":"R15551511","doi-asserted-by":"crossref","unstructured":"Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819\u20131825","DOI":"10.1001\/jama.270.15.1819"},{"key":"R15551513","doi-asserted-by":"crossref","unstructured":"Kuhs H, Rudolf GAE: Cardiovascular effects of paroxetine. Psychopharmacology (Berl) 1990; 102:379\u2013382","DOI":"10.1007\/BF02244107"},{"key":"R15551515","doi-asserted-by":"crossref","unstructured":"Cardiac Arrhythmia Pilot Study (CAPS) Investigators: The Cardiac Arrhythmia Pilot Study. Am J Cardiol 1986; 57:91\u201395","DOI":"10.1016\/0002-9149(86)90958-6"},{"key":"R15551516","doi-asserted-by":"crossref","unstructured":"Roose SP, Glassman AH, Giardina EGV, Johnson LL, Walsh BT, Woodring S, Bigger JT Jr: Nortriptyline in depressed patients with left ventricular impairment. JAMA 1986; 256:3253\u20133257","DOI":"10.1001\/jama.256.23.3253"},{"key":"R15551517","doi-asserted-by":"crossref","unstructured":"Roose SP, Glassman AH, Siris SG, Walsh BT, Bruno RL, Wright LB: Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmacol 1981; 1:316\u2013319","DOI":"10.1097\/00004714-198109000-00008"},{"key":"R15551518","doi-asserted-by":"crossref","unstructured":"Glassman AH, Johnson LL, Giardina EGV, Walsh BT, Roose SP, Cooper TB, Bigger JT Jr: The use of imipramine in depressed patients with congestive heart failure. JAMA 1983; 250:1997\u20132001","DOI":"10.1001\/jama.250.15.1997"},{"key":"R15551519","doi-asserted-by":"crossref","unstructured":"Roose SP, Glassman AH, Giardina EGV, Johnson LL, Walsh BT, Bigger JT Jr: Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987; 7:247\u2013251","DOI":"10.1097\/00004714-198708000-00007"},{"key":"R15551520","unstructured":"Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EGV: Is doxepin a safer tricyclic for the heart? J Clin Psychiatry 1991; 52:338\u2013341"},{"key":"R15551521","doi-asserted-by":"crossref","unstructured":"Dalack GW, Roose SP, Glassman AH: Tricyclics and heart failure (letter). Am J Psychiatry 1991; 148:1601","DOI":"10.1176\/ajp.148.11.1601a"},{"key":"R15551523","doi-asserted-by":"crossref","unstructured":"Upward JW, Edwards JG, Goldie A, Waller DG: Comparative effects of fluoxetine and amitriptyline on cardiac function. Br J Clin Pharmacol 1988; 26:399\u2013402","DOI":"10.1111\/j.1365-2125.1988.tb03397.x"},{"key":"R15551524","doi-asserted-by":"crossref","unstructured":"Roose SP, Glassman AH, Attia E, Woodring S: Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151:1735\u20131739","DOI":"10.1176\/ajp.151.12.1735"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.5.660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T06:11:07Z","timestamp":1722406267000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.155.5.660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5,1]]}},"alternative-id":["10.1176\/ajp.155.5.660"],"URL":"https:\/\/doi.org\/10.1176\/ajp.155.5.660","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5,1]]}}}